Withdrawn trial sought new hope for stubborn blood cancer
Disease control
Terminated
This study aimed to see how well and how safe the pill tazemetostat was for adults whose follicular lymphoma, a type of blood cancer, had come back or stopped responding to treatment. It specifically focused on people whose cancer did not have a certain genetic change called an '…
Phase: PHASE2 • Sponsor: Epizyme, Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC